These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21186064)

  • 1. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
    Lysandropoulos AP; Jaquiéry E; Jilek S; Pantaleo G; Schluep M; Du Pasquier RA
    J Neuroimmunol; 2011 Apr; 233(1-2):240-4. PubMed ID: 21186064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
    Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
    J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of 1 alpha,25-dihydroxyvitamin D3 with IL-12 and IL-4 on cytokine expression of human T lymphocytes.
    Thien R; Baier K; Pietschmann P; Peterlik M; Willheim M
    J Allergy Clin Immunol; 2005 Sep; 116(3):683-9. PubMed ID: 16159643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis.
    Prabhu Anand S; Selvaraj P; Narayanan PR
    Cytokine; 2009 Feb; 45(2):105-10. PubMed ID: 19091593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
    Jensen J; Langkilde AR; Frederiksen JL; Sellebjerg F
    J Neuroimmunol; 2006 Oct; 179(1-2):163-72. PubMed ID: 16919783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
    Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
    Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis.
    Gausling R; Trollmo C; Hafler DA
    Clin Immunol; 2001 Jan; 98(1):11-7. PubMed ID: 11141321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
    Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
    Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
    Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
    J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis.
    Somma P; Ristori G; Battistini L; Cannoni S; Borsellino G; Diamantini A; Salvetti M; Sorrentino R; Fiorillo MT
    J Leukoc Biol; 2007 Mar; 81(3):696-710. PubMed ID: 17110420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cytokine gene expression in CD4+ and CD8+ T cell subsets of calves.
    Tanaka S; Aso H; Miyazawa K; Nagai Y; Watanabe K; Ohwada S; Kobayashi J; Yamaguchi T
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):84-91. PubMed ID: 17543393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.
    Laplaud DA; Ruiz C; Wiertlewski S; Brouard S; Berthelot L; Guillet M; Melchior B; Degauque N; Edan G; Brachet P; Damier P; Soulillou JP
    Brain; 2004 May; 127(Pt 5):981-95. PubMed ID: 14985265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
    Correale J; Ysrraelit MC; Gaitán MI
    J Immunol; 2010 Oct; 185(8):4948-58. PubMed ID: 20855882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells.
    Sochorová K; Budinský V; Rozková D; Tobiasová Z; Dusilová-Sulková S; Spísek R; Bartůnková J
    Clin Immunol; 2009 Oct; 133(1):69-77. PubMed ID: 19660988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
    Tsai YG; Yang KD; Niu DM; Chien JW; Lin CY
    J Immunol; 2010 Jun; 184(12):7229-37. PubMed ID: 20483759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between peripheral IFN-gamma producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis.
    Sepulcre J; Sanchez-Ibarrola A; Moreno C; de Castro P
    Cytokine; 2005 Oct; 32(2):111-6. PubMed ID: 16246570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.